Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Umapathi, T ^a   Hughes, Richard A C ^b   Nobile Orazio, Eduardo ^c   Léger, Jean Marc ^d  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d Groupe Hospitalier Pitrie Salpêtrière   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO;

CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FLU LIKE SYNDROME; GRIP STRENGTH; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MOTOR NEUROPATHY; MOTOR PERFORMANCE; MUSCLE ACTION POTENTIAL; MUSCLE STRENGTH; PLASMAPHERESIS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW;

EID: 70249128280     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003217.pub3     Document Type: Review

References (120)

1. Piepers S, Van den Berg-Vos R, Van der Pol WL, FranssenH,Wokke J, Van den Berg L. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. Brain 2007;130(Pt 8):2004-2010 [MEDLINE: 11966] (Pubitemid 47236626)
2. Abbruzzese M, Reni L, Schenone A, Mancardi GL, Primavera A. Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis. Neurology 1997;48(2):544. [MEDLINE: 97193169] (Pubitemid 27087643)
3. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000;47(2-3):85-118. [MEDLINE: 12004]
4. Axelson HW, Oberg G, Askmark H. No benefit of treatment with cyclophosphamide and autologous blood stemcell transplantation in multifocal motor neuropathy. Acta Neurologica Scandinavica 2008;117(6):432-434 (Pubitemid 351643672)
5. Azulay JP, Blin O, Pouget J, Boucraut J, Bille-Turc F, Carles G, et al.Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 1994;44(3 Pt 1):429-432 [MEDLINE: 94195493] (Pubitemid 24098139)
6. Azulay JP, Rihet P, Pouget J, Cador F, Blin O, Boucraut J, et al.Long term follow up of multifocal motor neuropathy with conduction block under treatment. Journal of Neurology, Neurosurgery and Psychiatry 1997;62(4):391-394 [MEDLINE: 97252580] (Pubitemid 27199114)
7. Benedetti L,GrandisM,Nobbio L, BeronioA,GhiglioneE,Manzino M, et al.Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. Muscle & Nerve 2004;29(5):748-749
8. Bentes C, CarvalhoM, Evangelista T, Sales-LuisML.Multifocal motor neuropathy mimicking motor neuron disease: nine cases. Journal of the Neurological Sciences 1999;169(1-2):76-79 [MEDLINE: 20009703] (Pubitemid 29502510)
9. Beydoun SR. Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies. Muscle & Nerve 1998;21(6):813-815 [MEDLINE: 98244739]
10. Beydoun SR, Copeland D. Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block. Muscle & Nerve 2000;23(4):556-559 [MEDLINE: 12008] (Pubitemid 30164782)
11. Bouche P, Moulonguet A, Younes-Chennoufi AB, Adams D, Baumann N, Meininger V, et al.Multifocal motor neuropathy with conduction block: a study of 24 patients. Journal of Neurology, Neurosurgery and Psychiatry 1995;59(1):38-44. [MEDLINE: 95332895]
12. Brannagan TH 3rd, Alaedini A, Gladstone DE. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle & Nerve 2006;34(2):246-250 [MEDLINE: 12009]
13. Carpo M, Cappellari A, Mora G, Pedotti R, Barbieri S, Scarlato G, et al.Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 1998;50(5):1480-1482 [MEDLINE: 98255453] (Pubitemid 28240378)
14. Chad DA,Hammer K, Sargent J. Slow resolution ofmultifocal weakness and fasciculation: a reversible motor neuron syndrome. Neurology 1986;36(9):1260-1263 [MEDLINE: 86311808] (Pubitemid 16047012)
15. CharlesN,BenoitP,VialC,BiermeT,MoreauT,BadyB. Intravenous immunoglobulin treatment in multifocal motor neuropathy. Lancet 1992;340(8812):182. [MEDLINE: 92326500]
16. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Drachman DB, Freimer ML, et al.Multifocal motor neuropathy: response to human immune globulin. Annals of Neurology 1993;33(3):237-242 [MEDLINE: 93270420] (Pubitemid 23081153)
17. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Adornato B, Miller RG, et al.Maintenance immune globulin therapy for multifocal motor neuropathy: results of long term follow-up. Annals of Neurology 1996;40:513-514
18. Chaudhry V, Cornblath DR, Griffin JW, O'Brien R,Drachman DB. Mycophenolatemofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 2001;56(1):94-96 [MEDLINE: 12010] (Pubitemid 32059658)
19. Chaudhry V, SwashM.Multifocal motor neuropathy: is conduction block essential?. Neurology 2006;67(4):558-559 [MEDLINE: 1] (Pubitemid 44273596)
20. Ciafaloni E,MasseyJM,Tucker-LipscombB, SandersDB.Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology 2001;56(1):97-99 [MEDLINE: 12041]
21. Cisternas M, Gutierrez M, Jacobelli S. Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article byMohan et al. Arthritis and Rheumatism 2002;46(11):3107-3108 [MEDLINE: 12034] (Pubitemid 35315913)
22. Claus D, Specht S, ZieschangM. Plasmapheresis inmultifocal motor neuropathy: a case report. Journal of Neurology, Neurosurgery and Psychiatry 2000;68(4):533-535 [MEDLINE: 20297614] (Pubitemid 30248763)
23. Cocito D, Bergamasco B, Tavella A, Poglio F, Paolasso I, Costa P, et al.Multifocal motor neuropathy during treatment with infliximab. Journal of the Peripheral Nervous System 2005;10(4):386-387 [MEDLINE: 12033] (Pubitemid 43920044)
24. Comi G, Amadio S, Galardi G, Fazio R, Nemni R. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. Journal of Neurology, Neurosurgery and Psychiatry 1994;57 Suppl:35-37 [MEDLINE: 95054150] (Pubitemid 24356104)
25. Cornblath DR, Sumner AJ, Daube J, Gilliat RW, Brown WF, Parry GJ, et al.Conduction block in clinical practice. Muscle&Nerve 1991;14(9):869-871 [MEDLINE: 92018002]
26. Corse AM, Chaudhry V, Crawford TO, Cornblath DR, Kuncl RW, Griffin JW. Sensory nerve pathology inmultifocalmotor neuropathy. Annals of Neurology 1996;39(3):319-325 [MEDLINE: 96180909] (Pubitemid 26100755)
27. CruzMartinez A, Arpa J, LaraM. Electrophysiological improvement after intravenous immunoglobulin in motor neuropathy with multifocal conduction block [letter]. Journal of Neurology, Neurosurgery and Psychiatry 1993;56(11):1236- 1237 [MEDLINE: 94045726] (Pubitemid 23323671)
28. de Carvalho M, Luis ML. Relapsing chronic low-dose corticosteroid responsive multifocal motor neuropathy with conduction block. Electromyography and Clinical Neurophysiology 1997;37(2): 95-97 [MEDLINE: 97253230]
29. Delmont E, Azulay JP, Giorgi R, Attarian S, Verschueren A, Uzenot D, et al.Multifocal motor neuropathy with and without conduction block: a single entity?. Neurology 2006;67(4):592-596 [MEDLINE: 12040] (Pubitemid 44273604)
30. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N, et al.Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. Journal of Neurology, Neurosurgery and Psychiatry 1994;57(7): 778-783 [MEDLINE: 94292989] (Pubitemid 24214955)
31. Hughes R. 79th ENMC International Workshop: Multifocal motor neuropathy, 14-15 April 2000, Hilversum, The Netherlands. Neuromuscular Disorders 2001;11:309-314 [MEDLINE: 21194983]
32. Estrada-Acosta R, Lestayo-O'Farrill Z, Coba-Morales C. Multifocal motor neuropathy with block of nerve conduction. Report of three cases. Revista de Neurologica 1999;29(2):130-133 [MEDLINE: 99457632] (Pubitemid 29459330)
33. Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, et al.Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. Journal of the American Academy of Dermatology 2007;56(4):624-628 [MEDLINE: 12031] (Pubitemid 46400174)
34. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE. Multifocal motor neuropathy improved by IVIg: randomized, doubleblind, placebo-controlled study [In Process Citation]. Neurology 2000;55(9):1256-1262 [MEDLINE: 20540715] (Pubitemid 30829363)
35. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Annals of Neurology 1991;30(3):397-401. [MEDLINE: 92060891]
36. Finsterer J, Schwerer B, Bittner RE, Mamoli B. Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy. Clinical Neuropathology 1999;18(1):31-36 [MEDLINE: 99140635] (Pubitemid 29039725)
37. Finsterer J, Derfler K. Immunoadsorption in multifocal motor neuropathy. Journal of Immunotherapy 1999;22(5):441-442 [MEDLINE: 20013483]
38. Gorson KC, Ropper AH, Weinberg DH. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy. Muscle & Nerve 1999;22(6):758-765 [MEDLINE: 99292352]
39. GorsonKC,NatarajanN,RopperAH,Weinstein R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle & Nerve 2007;35(1):66-69 [MEDLINE: 11714]
40. Halloran P,MathewT,Tomlanovich S,GrothC,Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled ef- ficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997;63(1):39-47. [MEDLINE: 12030]
41. Hausmanowa-Petrusewicz I, Rowinska-Marcinska K, Kopec A. Chronic acquired demyelinating motor neuropathy. Acta Neurologica Scandinavia 1991;84(1):40-45 [MEDLINE: 92024859]
42. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
43. Hoang-Xuan K, Léger JM, Ben Younes-Chennoufi A, Saidi H, Bouche P, Baumann N, et al.Treatment of immune deficient neuropathies with intravenous polyvalent immunoglobulins. An open study of 16 cases. Revue Neurologique 1993;149(6-7):385-392 [MEDLINE: 94135107]
44. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, et al.Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. Journal of Rheumatology 2003;30(10):2287-2291 [MEDLINE: 12029] (Pubitemid 37221866)
45. Jaspert A, Claus D, Grehl H, Neundorfer B. Multifocal motor neuropathy: clinical and electrophysiological findings. Journal of Neurology 1996;243(10):684-692 [MEDLINE: 97082057] (Pubitemid 26371924)
46. Kaji R, ShibasakiH, Kimura J.Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 1992;42(3 Pt 1):506-509 [MEDLINE: 92195451]
47. Kaji R, Oka N, Tsuji T, Mezaki T, Nishio T, Akiguchi I, et al.Pathological findings at the site of conduction block in multifocal motor neuropathy. Annals of Neurology 1993;33(2):152-158 [MEDLINE: 93167760] (Pubitemid 23039923)
48. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle & Nerve 1991;14(11):1103-1109 [MEDLINE: 92079974]
49. Komiyama A, Toda H, Hasegawa O, Kuroiwa Y. Multifocal motor neuropathy. Neurology 1998;50(1):314. [MEDLINE: 98103748]
50. Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti- GM1 antibody testing. Muscle & Nerve 1994;17(1):100-104 [MEDLINE: 94088629] (Pubitemid 24012110)
51. Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 1990;40(1):118-127 [MEDLINE: 90114647] (Pubitemid 20032904)
52. Lange DJ, Trojaborg W, Latov N, Hays AP, Younger DS, Uncini A, et al.Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?. Neurology 1992;42(3 Pt 1):497-505. [MEDLINE: 92195450]
53. Le Forestier N, Chassande B, Moulonguet A, Masionobe T, Schaeffer S, Birouk N, et al.Multifocal motor neuropathy with conduction block: 39 cases. Revue Neurologique 1997;153(10):579-586 [MEDLINE: 98348647] (Pubitemid 27488134)
54. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32(9):958-964 [MEDLINE: 82272991]
55. Lewis RA. Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities [letter; comment]. Muscle & Nerve 1999;22(12):1738-1739 [MEDLINE: 20035371]
56. Léger JM, Younes-Chennoufi AB, Chassande B, DavilaG, Bouche P, Baumann N, et al.Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. Journal ofNeurology, Neurosurgery and Psychiatry 1994; November 57 Suppl:46-49 [MEDLINE: 95054153]
57. Léger JM, Chassande B,Musset L,Meininger V, Bouche P, Baumann N. Intravenous immunoglobulin therapy in multifocal motor neuropathy: A double-blind, placebo-controlled study. Brain 2001;124 (Pt 1):145-153 [MEDLINE: 20575579] (Pubitemid 32055996)
58. Léger JM, Viala K,Cancalon F,Maisonobe T,Gruwez B,Waegemans T, et al.Intravenous immunoglobulin as short- and long-termtherapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients. Journal of Neurology, Neurosurgery & Psychiatry 2008;79(1):93-96 [MEDLINE: 12028]
59. Martina IS, van Doorn PA, Schmitz PI, Meulstee J, van der Meché FG.Chronicmotor neuropathies: response to interferon-beta1a after failure of conventional therapies. Journal of Neurology, Neurosurgery and Psychiatry 1999;66(2):197-201. [MEDLINE: 99168657] (Pubitemid 29103521)
60. Meriggioli MN, Rowin J, Richman JG, Leurgans S. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Annals of the New York Academy of Sciences 2003;998: 494-499 [MEDLINE: 10537] (Pubitemid 37194203)
61. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. Journal of Neurology, Neurosurgery and Psychiatry 1997;63(6):765-769 [MEDLINE: 98077295] (Pubitemid 27520754)
62. Mezaki T, Kaji R, Kimura J.Multifocal motor neuropathy and Lewis Sumner syndrome: a clinical spectrum. Muscle & Nerve 1999;22 (12):1739-1740 [MEDLINE: 20035372]
63. Mowzoon N, Sussman A, Bradley WG. Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis. Journal of the Neurological Sciences 2001;185(2):119-122 [MEDLINE: 12027] (Pubitemid 32318516)
64. Nemni R, Santuccio G, Calabrese E, Galardi G, Canal N. Efficacy of cyclosporine in multifocal motor neuropathy. Journal of Neurology 2003;250(9):1118-1120 (Pubitemid 37152565)
65. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43(3 Pt 1):537-544 [MEDLINE: 93196886] (Pubitemid 23088488)
66. Nobile-Orazio E.Multifocal motor neuropathy. Journal of Neuroimmunology 2001;115(1-2):4-18. [MEDLINE: 21179317]
67. Nobile-Orazio E, Cappellari A, Meucci N, Carpo M, Terenghi F, Bersano A, et al.Multifocalmotor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree ofmotor conduction block. Journal ofNeurology, Neurosurgery & Psychiatry 2002;72(6):761-766 [MEDLINE: 12026] (Pubitemid 34557021)
68. Oh SJ, Claussen GC, Kim DS. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic in- flammatory demyelinating polyneuropathy?. Journal of the Peripheral Nervous System 1997;2(4):362-369 [MEDLINE: 20427485]
69. Oh SJ. Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity?. Neurology 2000;55(5):735-742 [MEDLINE: 20438675]
70. Olney RK, Lewis RA, Putnam TD, Campellone JV Jr. American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis ofmultifocal motor neuropathy. Muscle & Nerve 2003;27(1):117-121
71. Oxford Grice K, Vogel KA, Le V,Mitchell A,Muniz S, Vollmer MA. Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. American Journal of Occupational Therapy 2003;57 (5):570-573 [MEDLINE: 12014]
72. Pakiam AS, Parry GJ. Multifocal motor neuropathy without overt conduction block. Muscle&Nerve 1998;21(2):243-245 [MEDLINE: 98126078]
73. Parry GJ, Clarke S. Pure motor neuropathy with multifocal conduction block masquerading as motor neuron disease. Muscle & Nerve 1985;8(6):167 (abstract).
74. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle & Nerve 1988;11(2): 103-107 [MEDLINE: 88142945] (Pubitemid 18039607)
75. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, et al.A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Annals of Neurology 1988;24(1):73-78 [MEDLINE: 88325299] (Pubitemid 18171378)
76. Pestronk A, Chaudhry V, Feldman EL, Griffin JW, Cornblath DR, Denys EH, et al.Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of anti-glycolipid antibodies. Annals of Neurology 1990;27(3):316-326 [MEDLINE: 90225693] (Pubitemid 20122384)
77. Pestronk A. Neuromuscular Disease Center, Washington University School of Medicine. http://www.neuro.wustl.edu/neuromuscular.
78. Pestronk A, Florence J, Miller T, Choksi, Al-Lozi MT, Levine TD. Treatment of IgMantibody associated polyneuropathies using rituximab. Journal of Neurology, Neurosurgery and Psychiatry 2003;74(4):485-489 [PUBMED: 12640069] (Pubitemid 36379372)
79. Pisoni CN, CuadradoMJ, KhamashtaMA,Hughes GR, D'CruzDP. Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) 2007;46(3):516-518 [MEDLINE: 12025]
80. Pringle CE, Belden MD, Veitch JE, Brown WF. Multifocal motor neuropathy presenting as ophthalmoplegia. Muscle & Nerve 1997;20(3):347-351 [MEDLINE: 97205310]
81. Radziwill AJ, Schweikert K, Kuntzer T, Fuhr P, Steck AJ. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study. European Neurology 2006;56 (1):37-38 [MEDLINE: 12024] (Pubitemid 44359541)
82. Rhee EK, England JD, Sumner AJ. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Annals of Neurology 1990;28(2):146-156 [MEDLINE: 91024070]
83. Richette P, Dieude P, Damiano J, Liote F, Orcel P, Bardin T. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. Journal of Rheumatology 2004;31(10): 2079-2081 [MEDLINE: 12023] (Pubitemid 39336740)
84. Richez C, Blanco P, Lagueny A, Schaeverbeke T, Dehais J. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology 2005;64(8):1468-1470 [MEDLINE: 12022] (Pubitemid 40570527)
85. Rodriguez-Escalera C, Belzunegui J, Lopez-Dominguez L, Gonzalez C, Figueroa M. Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy. Rheumatology (Oxford) 2005;44(1):132-133 [MEDLINE: 12021] (Pubitemid 40124349)
86. Rojas-Garcia R, Gallardo E, de Andres I, de Luna N, Juarez C, Sanchez P, et al.Chronic neuropathy with IgManti-ganglioside antibodies: lack of response to rituximab. Neurology 2003;61(12):1814-1816 [PUBMED: 14694058] (Pubitemid 38020840)
87. Gutierrez Ronquillo JH, Andrade Machado R, Machado Rojas A, Garcia Espinosa A. Multifocal motor neuropathy with partial block nerve conduction. Revista de Neurologica 2001;32(5):427-430. [MEDLINE: 21244716]
88. Roth G, Rohr J, Magistris MR, Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. European Journal of Neurology 1986;25(6):416-423 [MEDLINE: 87080468]
89. Ruegg SJ, Fuhr P, Steck AJ. Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg. Neurology 2004;63 (11):2178-2179 [MEDLINE: 12020] (Pubitemid 39636279)
90. Sanders DB, Hart IK, Mantegazza R, Shukla SS, Siddiqi ZA, De Baets MH, Melms A, Nicolle MW, Solomons N, Richman DP. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 2008;71(6):400-406 [PUBMED: 18434638 ]
91. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, et al.Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle & Nerve 1999;22(5): 560-566 [MEDLINE: 99260196]
92. Sharrack B, Hughes RAC. The Guy's Neurological Disability Rating Scale (GNDS): a new disability measure for multiple sclerosis. Multiple Sclerosis 1999;5(4):223-233 [MEDLINE: 9261] (Pubitemid 29405617)
93. Singer OC, Otto B, Steinmetz H, Ziemann U. Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy. Neurology 2004;63(9):1754. [MEDLINE: 12019] (Pubitemid 39507613)
94. Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007;69 (17):1680-1687 [MEDLINE: 11879] (Pubitemid 350287124)
95. Tan E, Lynn J, Amato AA, Kissel JT, Rammohan KW, Sahenk Z, et al.Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish treatable disease. Archives of Neurology 1994; 51(2):194-200. [MEDLINE: 94137142] (Pubitemid 24051583)
96. Taylor BV, Gross L,Windebank AJ. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 1996;47(1):951-955 [MEDLINE: 97010692]
97. Taylor BV, Wright RA, Harper CM, Dyck PJ. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle & Nerve 2000;23(6):900-908 [MEDLINE: 20303009]
98. Tektonidou MG, Serelis J, Skopouli FN. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment. Clinical Rheumatology 2007;26(2):258-260 [MEDLINE: 12017] (Pubitemid 46020257)
99. Terenghi F, Cappellari A, Bersano A, Carpo M, Barbieri S, Nobile-Orazio E. How long is IVIg effective in multifocal motor neuropathy?. Neurology 2004;62(4):666-668 [PUBMED: 14981195] (Pubitemid 38252820)
100. Terenghi F, Allaria S,Nobile-Orazio E.Circulating levels of cytokines and their modulation by intravenous immunoglobulin in multifocal motor neuropathy. Journal of the Peripheral Nervous System 2006;11 (1):67-71. [MEDLINE: 12016] (Pubitemid 43344977)
101. Toscano A, Rodolico C, Benvenga S,Girlanda P, LauraM,Mazzeo A, et al.Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association. Neuromuscular Disorders 2002;12(6):566-568 [MEDLINE: 12015] (Pubitemid 34756830)
102. Umapathi T, Hughes R. Mycophenolate in treatment-resistant in- flammatory neuropathies. European Journal of Neurology 2002;9(6): 683-685
103. Van Asseldonk JTH, Van Den Berg LH, Wieneke GH, Wokke JHJ. Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. Brain 2006;129(9):2447-2460 [PUBMED: 16923956]
104. Van den Berg LH, Kerkhoff H, Oey PL, Franssen H, Mollee I, Vermeulen M, et al.Treatment ofmultifocalmotor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. Journal of Neurology, Neurosurgery and Psychiatry 1995;59(3):248-252 [MEDLINE: 95404236]
105. Van den Berg LH, Lokhorst H, Wokke JHJ. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 1997;48(4):1135. [MEDLINE: 97264048] (Pubitemid 27175657)
106. Van den Berg LH, Franssen H, Wokke JH. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 1998;121(Pt 3):421-428 [MEDLINE: 98210686] (Pubitemid 28116339)
107. Van den Berg-VosRM, Van den Berg LH, FranssenH, VermeulenM, Witkamp TD, Jansen GH, et al.Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?. Neurology 2000;54(1):26-32. [MEDLINE: 20100076]
108. Van den Berg-Vos RM, Van den Berg LH, Franssen H, Van Doorn PA, Merkies IS, Wokke JH. Treatment of multifocal motor neuropathy with interferon-beta1a. Neurology 2000;54(7):1518-1521 [MEDLINE: 20215063] (Pubitemid 30210477)
109. Van den Berg-Vos RM, Franssen H, Wokke JH, Van Es HW, Van den Berg LH. Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Annals of Neurology 2000;48(6):919-926 [MEDLINE: 21003611]
110. Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH. Multifocal motor neuropathy:long term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 2002;125(Pt 8):1875-1886 (Pubitemid 34885714)
111. Van den Bergh P, Logigian EL, Kelly JJ Jr. Motor neuropathy with multifocal conduction blocks. Muscle & Nerve 1989;12(1):26-31. [MEDLINE: 89314031]
112. Van Es HW, Van den Berg LH, Franssen H, Witkamp TD, Ramos LM, Notermans NC, et al.Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997;48(5):1218-1224 [MEDLINE: 97297814] (Pubitemid 27240537)
113. van Schaik IN, Vermeulen MM, de Haan R, van den Berg LH. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database of Systematic Reviews 2005, Issue 2.. [DOI: 10.1002/14651858]
114. van Schaik I, Bouche P, Illa I, Leger JM, Van den BP, Cornblath DR, et al.European Federation ofNeurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Journal of the Peripheral Nervous System 2006;13(8):802-808 [MEDLINE: 20] (Pubitemid 44124675)
115. Van Swieten JC, Koudstaal PJ, VisserMC, Schouten HJA, Van Gijn J. Interobserver agreement for assessment of handicap in stroke patients. Stroke 1988;19(5):604-607 [MEDLINE: 88205437] (Pubitemid 18126965)
116. Viala K, Renie L, Maisonobe T, Behin A, Neil J, Leger JM, et al.Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 2004;127(Pt 9):2010-2017 (Pubitemid 39150259)
117. Vrethem M, Lindvall B, Kihlstrand S, Backman E, Brismar T, Fredman P, et al.High-dose intravenous immunoglobulin therapy improved muscle strength in a patient with multifocal motor neuropathy and antibodies against the gycolipid LK1. European Journal of Neurology 1996;3(2):156-159 (Pubitemid 26141463)
118. Vucic S, Black KR, Chong PST, Cros D.Multifocal motor neuropathy: decrease in conduction blocks and reinnvervation with longterm IVIg. Neurology 2004;63(7):1264-1269 (Pubitemid 39350028)
119. WillisonHG,Veitch J, SwanAV, BaumannN,ComiG,GregsonNA, et al.Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. European Journal of Neurology 1999;6(1):71-77
120. Yuki N, Yamazaki M, Kondo H, Suzuki K, Tsuji S. Treatment of multifocal motor neuropathy with a high dosage of intravenous immunoglobulin. Muscle & Nerve 1993;16(2):220-1. [MEDLINE: 93156761] *Indicates the major publication for the study (Pubitemid 23031013)